Drugs / CARDIOVIS COLESTEROLO
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03216811 | Jul → Oct 2017 | hyperlipidemia | University Hospital of Ferrara | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CARDIOVIS COLESTEROLO | “The purpose of the present study was to assess the effectiveness of CARDIOVIS COLESTEROLO 3 mg (containing red rice fermented with Monascus purpureus titrated with 3% monacolin...” NCT03216811 ↗ |
| Action | Inhibit | “especially monacolin K, that is an inhibitor of the hydroxymethylglutaryl-CoA enzyme” NCT03216811 ↗ |
| Modality | Other / unclassified | “CARDIOVIS COLESTEROLO 3 mg (containing red rice fermented with Monascus purpureus titrated with 3% monacolin K, hydrol mixture of olive fruit titrated with vitamin E, Coenzyme...” NCT03216811 ↗ |
| Route | Oral | “assigned to receive a daily oral dose of CARDIOVIS COLESTEROLO 3 mg” NCT03216811 ↗ |